Antiviral formulation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/107 (2006.01) A61K 9/00 (2006.01) A61K 31/52 (2006.01) A61K 47/10 (2006.01) A61P 31/22 (2006.01)

Patent

CA 2717440

A topical antiviral composition comprising acyclovir, penciclovir and/or omaciclovir in a glucocorticoid-free phar-maceutical carrier comprising 15 to 25 weight % propylene glycol and 10 to 25 weight % isopropyl C12-C22 alkanoic ester. The compositions have utility in the treatment or prophylaxis of herpesvirus infections. Clinical results demonstrate that treatment commencing at the prodromal stage can prevent the development of a classic cold sore lesion in a large proportion of patients.

L'invention porte sur une composition antivirale topique comprenant de l'acyclovir, du penciclovir et/ou de l'omaciclovir dans un support pharmaceutique exempt de glucocorticoïde comprenant 15 à 25 % en poids de propylène glycol et 10 à 25 % en poids d'ester isopropylique d'acide alcanoïque en C12-C22. Les compositions ont une utilité dans le traitement ou la prophylaxie d'infections par le virus de l'herpès. Les résultats cliniques démontrent qu'un traitement commençant au stade prodormal peut empêcher le développement d'une lésion classique de bouton de fièvre dans une proportion importante de patients.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antiviral formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiviral formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral formulation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1815483

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.